Ireland - English - HPRA (Health Products Regulatory Authority)

milpharm limited - cefuroxime axetil (amorphous) - film coated tablet - 250 milligram - cephalosporins and related substances - antibacterials for systemic use, second-generation cephalosporins - cefuroxime milpharm is indicated for the treatment of the infections listed below in adults and children from the age of 3 months • acute streptococcal tonsillitis and pharyngitis. • acute bacterial sinusitis. • acute otitis media. • acute exacerbations of chronic bronchitis. • cystitis. • pyelonephritis. • uncomplicated skin and soft tissue infections. • treatment of early lyme disease.

Ireland - English - HPRA (Health Products Regulatory Authority)

milpharm limited - cefuroxime axetil (amorphous) - film coated tablet - 500 milligram - cephalosporins and related substances - antibacterials for systemic use, second-generation cephalosporins - acute streptococcal tonsillitis and pharyngitis. acute bacterial sinusitis. acute otitis media. acute exacerbations of chronic bronchitis. cystitis. pyelonephritis. uncomplicated skin and soft tissue infections. treatment of early lyme disease.

Malta - English - Medicines Authority

anfarm hellas s.a. 4 achaias str. & trizinias 14564 kifissia, attiki, greece - ceftriaxone - powder for solution for infusion - ceftriaxone 2 g - antibacterials for systemic use

Ireland - English - HPRA (Health Products Regulatory Authority)

aurobindo pharma (malta) limited - cefuroxime axetil (amorphous) - film-coated tablet - 250 milligram(s) - cephalosporins and related substances

Ireland - English - HPRA (Health Products Regulatory Authority)

aurobindo pharma (malta) limited - cefuroxime axetil (amorphous) - film-coated tablet - 500 milligram(s) - cephalosporins and related substances

Israel - English - Ministry of Health

genmedix , israel - vancomycin as hydrochloride - lyophilized powder for concentrated solution - vancomycin as hydrochloride 500 mg/vial - vancomycin - vancomycin - vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-iactam-resistant) staphylococci. it is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs.vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal infections are purulent and localized. for endocarditis due to streptococcus viridans or streptococcus bovis vancomycin hydrochloride has been shown to be effective in combination with an aminoglycoside. vancomycin hydrochloride has been shown to be effective only in combination with an aminoglycoside for endocarditis due to enterococci (eg enterococcus fecalis). vancomycin hydrochloride has been shown to be effective for the treatment of diphtheroid endocareditis. in early-onset prosthetic valve endocarditis caused by staphylococcus epidermidis or diptheroids vancomycin hydrochloride has been administered successfully in combination with either rifampin an aminoglycoside or combined with both drugs. bacteriologic cultures of specimens should be obtained for isolation and identification of causative organisms and determination of susceptibilities to vancomycin hydrochloride. oral therapy vancomycin hydrochloride injection may be given orally for the treatment of antibiotic-associated pseudomembrannous colitis due to staphylococcus enterocolitis and clostridium difficile. vancomycin hydrochloride is not effective orally when administered for other types of infection.

Israel - English - Ministry of Health

genmedix , israel - vancomycin as hydrochloride - lyophilized powder for concentrated solution - vancomycin as hydrochloride 500 mg/vial - vancomycin - vancomycin - vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-iactam-resistant) staphylococci. it is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. antibiotic therapy is as an adjunct to appropriate surgical measures when sta

Israel - English - Ministry of Health

genmedix , israel - vancomycin as hydrochloride - lyophilized powder for concentrated solution - vancomycin as hydrochloride 1000 mg/vial - vancomycin - vancomycin - vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-iactam-resistant) staphylococci. it is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs.vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal infections are purulent and localized. for endocarditis due to streptococcus viridans or streptococcus bovis vancomycin hydrochloride has been shown to be effective in combination with an aminoglycoside. vancomycin hydrochloride has been shown to be effective only in combination with an aminoglycoside for endocarditis due to enterococci (eg enterococcus fecalis). vancomycin hydrochloride has been shown to be effective for the treatment of diphtheroid endocareditis. in early-onset prosthetic valve endocarditis caused by staphylococcus epidermidis or diptheroids vancomycin hydrochloride has been administered successfully in combination with either rifampin an aminoglycoside or combined with both drugs. bacteriologic cultures of specimens should be obtained for isolation and identification of causative organisms and determination of susceptibilities to vancomycin hydrochloride. oral therapy vancomycin hydrochloride injection may be given orally for the treatment of antibiotic-associated pseudomembrannous colitis due to staphylococcus enterocolitis and clostridium difficile. vancomycin hydrochloride is not effective orally when administered for other types of infection.

Israel - English - Ministry of Health

genmedix , israel - vancomycin as hydrochloride - lyophilized powder for concentrated solution - vancomycin as hydrochloride 1 g/vial - vancomycin - vancomycin - vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-iactam-resistant) staphylococci. it is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. antibiotic therapy is as an adjunct to appropriate surgical measures when stap

Malta - English - Medicines Authority

pharmsol europe limited the victoria centre unit 2, lower ground floor, valletta road, mosta mst 9012 , malta - cefazolin sodium - powder for solution for injection/infusion - cefazolin sodium 1 g - antibacterials for systemic use